Brief: Viemed Healthcare Q2 Revenue USD 63.056 Million

Viemed Healthcare

06/08/2025 22:12

Overview

Viemed Healthcare Q2 2025 net revenue rises 14.7% yr/yr to $63.1 mln

Net income for Q2 2025 jumps 115.1% yr/yr to $3.2 mln

Co repurchased 270,061 shares, signaling strategic capital use

Outlook

Viemed expects 2025 revenue between $271 mln and $277 mln

Company anticipates 2025 adjusted EBITDA of $59 mln to $62 mln

Revenue guidance increased due to Lehans acquisition impact

Result Drivers

PATIENT COUNT GROWTH - Increase in ventilator and PAP therapy patient counts contributed to revenue growth

EXPENSE LEVERAGING - Continued leveraging of expenses aided in meeting organic growth targets

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
$63.06 mln
Q2 Net Income
$3.25 mln
Q2 Gross Profit
$36.73 mln
Q2 Income from Operations
$5.10 mln
Q2 Pretax Profit
$4.96 mln


Analyst Coverage

The stock recently traded at 15 times the next 12-month earnings vs. a P/E of 17 three months ago

Press Release: ID:nACSXLlCVa

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)